About Cannara Biotech
Cannara Biotech is a company based in Montreal (Canada) founded in 2018 by Zohar Krivorot. Cannara Biotech has raised $17.66 million across 5 funding rounds from investors including Canadian Imperial Bank of Commerce, FSD Pharma and Phoenician Capital. The company has 363 employees as of August 31, 2024. Cannara Biotech has completed 1 acquisition, including Shop CBD. Cannara Biotech offers products and services including Dried Flowers, Pre-Rolls, and Cannabis Oils. Cannara Biotech operates in a competitive market with competitors including Canopy Growth, Organigram, C21 Investments, PharmaCielo and Aphria, among others.
- Headquarter Montreal, Canada
- Employees 363 as on 31 Aug, 2024
- Founders Zohar Krivorot
- Stage Public
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cannara Biotech, Inc.
-
Annual Revenue
$56.82 M (USD)42.77as on Aug 31, 2024
-
Net Profit
$4.48 M (USD)-7.3as on Aug 31, 2024
-
EBITDA
-$8.03 M (USD)-160.19as on Aug 31, 2024
-
Total Equity Funding
$17.66 M (USD)
in 5 rounds
-
Latest Funding Round
$4.61 M (USD), Post-IPO
Feb 04, 2026
-
Investors
Canadian Imperial Bank of Commerce
& 2 more
-
Employee Count
363
as on Aug 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cannara Biotech
Cannara Biotech is a publicly listed company on the TSXV with ticker symbol LOVE in Canada, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cannara Biotech
Cannara Biotech offers a comprehensive portfolio of products and services, including Dried Flowers, Pre-Rolls, and Cannabis Oils.
Premium cultivated cannabis flowers for recreational and medical use.
Convenient pre-rolled cannabis for easy consumption.
Extracted oils from cannabis for versatile applications.
People of Cannara Biotech
Unlock access to complete
Funding Insights of Cannara Biotech
Cannara Biotech has successfully raised a total of $17.66M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $4.61 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cannara Biotech
Cannara Biotech has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce, FSD Pharma and Phoenician Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Commercial banking services are provided to individuals and businesses.
|
Locked | Locked | Locked | |
|
Cannabis company engaged in cultivation, processing, and manufacturing related activities
|
Locked | Locked | Locked |
Investor details for Cannara Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cannara Biotech
Cannara Biotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Shop CBD.
Investment portfolio details for Cannara Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Personal care products are retailed by Shop CBD in Canada.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Cannara Biotech
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cannara Biotech
Detailed financials for Cannara Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cannara Biotech Comparisons
Peer comparison for Cannara Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cannara Biotech
Cannara Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Canopy Growth, Organigram, C21 Investments, PharmaCielo and Aphria, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cannabis products are provided to support consumer wellness and health.
|
|
| Locked | Locked | Locked |
Provider of cannabis products, brands, and international business development investments
|
|
| Locked | Locked | Locked |
Cannabis and hemp-derived products are cultivated, processed, and supplied.
|
|
| Locked | Locked | Locked |
Medicinal cannabis oil and products are produced in Colombia.
|
|
| Locked | Locked | Locked |
Cannabis-derived nutritional and wellness products are provided by Aphria.
|
Detailed competitors of Cannara Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cannara Biotech
Complete news archive for Cannara Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cannara Biotech
Cannara Biotech was founded in 2018.
Cannara Biotech is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Zohar Krivorot is the current CEO of Cannara Biotech. They have also founded this company.
Cannara Biotech is a funded company, having raised a total of $17.66M across 5 funding rounds to date.
As of Aug 31, 2024, the latest employee count at Cannara Biotech is 363.
Annual revenue of Cannara Biotech is $56.82M as on Aug 31, 2024.
Cannara Biotech was established in 2018 in Montreal, Canada, as a facility focused on the medicinal cannabis sector. Organic cannabis is cultivated and infused with medicinal herbs and flowers. Cannabis oil is also extracted through specialized processes. Operations are centered on production for medicinal applications, with the company serving the Canadian market from its primary location.
Cannara Biotech's top competitors include Canopy Growth, Organigram and Aphria.
Cannara Biotech offers Dried Flowers, Pre-Rolls, and Cannabis Oils.
Yes, Cannara Biotech is publicly traded on TSXV under the ticker symbol LOVE.
Cannara Biotech has made 1 acquisition, including Shop CBD.
Cannara Biotech has 3 investors. Key investors include Canadian Imperial Bank of Commerce, FSD Pharma, and Phoenician Capital.
The ticker symbol of Cannara Biotech is LOVE on TSXV.